Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mawi DNA Technologies develops and commercializes innovative biosample collection technologies such as iSWAB and HemaSure. These enable non-invasive, room-temperature stable sample transport for applications in infectious disease surveillance, genomics, microbiome analysis, and more. Their iSWAB-Microbiome product was widely deployed during the COVID-19 pandemic due to its viral inactivation properties and ability to skip RNA extraction steps. The company’s HemaSure platform supports whole blood-based molecular testing programs such as HIV monitoring in Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mawid.